Welcome: Guest | Site Use Options | Register | Login |

Yuma Therapeutics Corporation

Yuma Therapeutics Corporation

Profile last edited on: 2/4/2020
77 Pond Avenue C1002
Brookline, MA 02445
  (617) 953-4618
Business Identifier: Disease-modifying pharmaceutical compounds targeting the tau pathway for Alzheimer's disease and other neurodegenerative diseases
Public Profile:
Yuma Therapeutics is a privately held biopharmaceutical company focused on developing novel disease-modifying drugs to treat neurodegenerative diseases. The firm develops disease-modifying pharmaceutical compounds to affect the disease progression of Alzheimer's disease and other neurodegenerative diseases. The compounds function through modulating cellular proteostasis to treat the neurodegenerative proteinopathies.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Brain Penetrant HSP90 Inhibitors for Alzheimer's Disease

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920